Nippon Telegraph and Telephone Corporation

Tokyo Metropolitan Institute of Medical Science

Kenichi Fukuda

Ippei Shake

Kazutaka Ikeda

Atsuhiko Maeda

Kazuaki Obana

Michiharu Takemoto

Yukio Kikuya

Tetsuo Kawano

Daisuke Nishizawa

Hiroshi Sato

Sunyong Kim

Provided is a technique for efficiently predicting the number (quantity) of occurrences of emergency medical service requests in a target area. An emergency medical service demand prediction device according to an embodiment obtains actual history data including information about dates and times of occurrences of emergency medical service requests, information about positions of the occurrences of the emergency medical service requests, and information about illnesses and injuries that caused the emergency medical service requests; the device generates a first learning model that receives an input of first learning-purpose data generated on a basis of learning-purpose actual history data and outputs illness/injury groups; the device generates a second learning model that receives an input of second learning-purpose data generated on a basis of the learning-purpose actual history data and the illness/injury groups output from the first learning model and outputs a value indicating a quantity of occurrences of emergency medical service requests for each unit area; and the device predicts a quantity of occurrences of emergency medical service requests in each unit area, by inputting, to the second learning model having been trained, prediction-purpose data generated on a basis of prediction-purpose actual history data and the illness/injury groups output from the first learning model having been trained.

Emergency demand prediction device, emergency demand prediction method, and program

The present invention provides a method for evaluating (predicting, etc.) an individual difference (the tendency of every individual) in terms of drug sensitivity and disease vulnerability, comprising using a gene polymorphism of a cyclic AMP responsive element binding protein gene or the like. The method for evaluating drug sensitivity and the method for evaluating disease vulnerability according to the present invention comprise associating a gene polymorphism of a cyclic AMP responsive element binding protein gene or a haplotype constituted by the gene polymorphism with the drug sensitivity and disease vulnerability of an individual.

Method for evaluating drug sensitivity and disease vulnerability by analyzing cyclic AMP responsive element binding protein gene

Growing community of inventors

Tokyo, Japan

Kenichi Fukuda